Home › Neoplasie del sangue › Maryland
Studi clinici su Neoplasie del sangue nello stato di Maryland
29 studi su Neoplasie del sangue cercano partecipanti presso sedi nello stato di Maryland.
Città nello stato di Maryland
Testo ufficiale dello studio (inglese)
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età da 18 a 110 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05724121Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 1
Età da 18 a 120 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06904066Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- MedStar Franklin Square Medical Center ( Site 0046), Baltimore
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056), Baltimore
- Maryland Oncology Hematology (MOH) ( Site 8000), Columbia
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- e altri 10
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
In reclutamentoFase 1 iniziale
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06398457Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 23, Baltimore
In reclutamentoFase 3
Età da 18 a 71 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT03816345Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 1/2Volontari sani benvenuti
Età da 12 a 120 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT05470491Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 1
Età da 18 a 75 · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07162038Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Johns Hopkins Asthma & Allergy Center, Baltimore
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07648264Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 1/2Volontari sani benvenuti
Età da 12 a 120 · Tutti i sessi · Aggiornato il 18 set 2026 · NCT05327023Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Christiana Care - Union Hospital, Elkton
- UM Saint Joseph Medical Center, Towson
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 17 set 2026 · NCT04242095The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 1/2Volontari sani benvenuti
Età da 12 a 120 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT05436418Longitudinal Studies of Patient With FPDMM
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionaleVolontari sani benvenuti
1 Day – 100 Years · Tutti i sessi · Aggiornato il 11 set 2026 · NCT03854318A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- The Center for Cancer and Blood Disorders, Bethesda
In reclutamentoStudio osservazionale
Età 0 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07154823Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
- John Hopkins University, Baltimore
In reclutamentoFase 1 iniziale
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT06184321Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
- Tania Jain, MD, Baltimore
In reclutamentoFase 1
6 Months – 80 Years · Tutti i sessi · Aggiornato il 14 ago 2026 · NCT02203903PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- Johns Hopkins Hospital, Baltimore
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 ago 2026 · NCT06665100A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- The Center for Cancer and Blood Disorders (CCBD), Bethesda
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 giu 2026 · NCT04068597Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 1/2Volontari sani benvenuti
Età da 12 a 85 · Tutti i sessi · Aggiornato il 11 giu 2026 · NCT04959175Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
- University of Maryland, Baltimore, Baltimore
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 giu 2026 · NCT06482515Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 giu 2026 · NCT05663502Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 18 a 120 · Tutti i sessi · Aggiornato il 27 mag 2026 · NCT06856226A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
In reclutamentoFase 3
Età da 2 a 18 · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT05711667A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Johns Hopkins School of Medicine, Baltimore
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 mar 2026 · NCT05735184Ocular Complications From Cancer Therapy - Patient Registry and Biobank
- Stoler Outpatient Cancer Center at the University of Maryland, Baltimore
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 mar 2026 · NCT06874283A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
- University of Maryland Medical Center, Baltimore
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 giu 2025 · NCT05768269Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Johns Hopkins University, Baltimore
- National Cancer Institute, Pediatric Oncology Branch, Bethesda
In reclutamentoFase 1
Età da 1 a 21 · Tutti i sessi · Aggiornato il 6 dic 2024 · NCT05476770Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.